#BEGIN_DRUGCARD DB02235

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
62697-73-8

# ChEBI_ID:
49033

# Chemical_Formula:
C5H11NO3S

# Chemical_IUPAC_Name:
(2R)-2-amino-4-[(S)-methanesulfinyl]butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Methionine Sulfoxide

# HET_ID:
SME

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-,10+/m1/s1

# InChI_Key:
InChIKey=QEFRNWWLZKMPFJ-KNODYTOMSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2235

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
165.211

# Molecular_Weight_Mono:
165.045963913

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1WMF

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-0.49

# Predicted_Water_Solubility:
5.40e+01 g/l

# Primary_Accession_No:
DB02235

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
9577091

# PubChem_Substance_ID:
46504569

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02921

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[S@](=O)CC[C@@H](N)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:55 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AB051423

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
PROF

# Drug_Target_1_Gene_Sequence:
>1923 bp
ATGAGAAAGAAGAAAAAGGTGTTTTTATCTGTTTTATCAGCTGCAGCGATTTTGTCGACT
GTTGCGTTAAGTAATCCATCTGCAGGTGGTGCAAGGAATTTTGATCTGGATTTCAAAGGA
ATTCAGACAACAACTGATGCTAAAGGTTTCTCCAAGCAGGGGCAGACTGGTGCTGCTGCT
TTTCTGGTGGAATCTGAAAATGTGAAACTCCCAAAAGGTTTGCAGAAGAAGCTTGAAACA
GTCCCGGCAAATAATAAACTCCATATTATCCAATTCAATGGACCAATTTTAGAAGAAACA
AAACAGCAGCTGGAAAAAACAGGGGCAAAGATTCTCGACTACATACCTGATTATGCTTAC
ATTGTCGAGTATGAGGGCGATGTTAAGTCAGCAACAAGCACCATTGAGCACGTGGAATCC
GTGGAGCCTTATTTGCCGATATACAGAATAGATCCCCAGCTTTTCACAAAAGGGGCATCA
GAGCTTGTAAAAGCAGTGGCGCTTGATACAAAGCAGAAAAATAAAGAGGTGCAATTAAGA
GGCATCGAACAAATCGCACAATTCGCAATAAGCAATGATGTGCTATATATTACGGCAAAG
CCTGAGTATAAGGTGATGAATGATGTTGCGCGTGGAATTGTCAAAGCGGATGTGGCTCAG
AGCAGCTACGGGTTGTATGGACAAGGACAGATCGTAGCGGTTGCCGATACAGGGCTTGAT
ACAGGTCGCAATGACAGTTCGATGCATGAAGCCTTCCGCGGGAAAATTACTGCATTATAT
GCATTGGGACGGACGAATAATGCCAATGATACGAATGGTCATGGTACGCATGTGGCTGGC
TCCGTATTAGGAAACGGCTCCACTAATAAAGGAATGGCGCCTCAGGCGAATCTAGTCTTC
CAATCTATCATGGATAGCGGTGGGGGACTTGGAGGACTACCTTCGAATCTGCAAACCTTA
TTCAGCCAAGCATACAGTGCTGGTGCCAGAATTCATACAAACTCCTGGGGAGCAGCAGTG
AATGGGGCTTACACAACAGATTCCAGAAATGTGGATGACTATGTGCGCAAAAATGATATG
ACGATCCTTTTCGCTGCCGGGAATGAAGGACCGAACGGCGGAACCATCAGTGCACCAGGC
ACAGCTAAAAATGCAATAACAGTCGGAGCTACGGAAAACCTCCGCCCAAGCTTTGGGTCT
TATGCGGACAATATCAACCATGTGGCACAGTTCTCTTCACGTGGACCGACAAAGGATGGA
CGGATCAAACCGGATGTCATGGCACCGGGAACGTTCATACTATCAGCAAGATCTTCTCTT
GCACCGGATTCCTCCTTCTGGGCGAACCATGACAGTAAATATGCATACATGGGTGGAACG
TCCATGGCTACACCGATCGTTGCTGGAAACGTGGCACAGCTTCGTGAGCATTTTGTGAAA
AACAGAGGCATCACACCAAAGCCTTCTCTATTAAAAGCGGCACTGATTGCCGGTGCAGCT
GACATCGGCCTTGGCTACCCGAACGGTAACCAAGGATGGGGACGAGTGACATTGGATAAA
TCCCTGAACGTTGCCTATGTGAACGAGTCCAGTTCTCTATCCACCAGCCAAAAAGCGACG
TACTCGTTTACTGCTACTGCCGGCAAGCCTTTGAAAATCTCCCTGGTATGGTCTGATGCC
CCTGCGAGCACAACTGCTTCCGTAACGCTTGTCAATGATCTGGACCTTGTCATTACCGCT
CCAAATGGCACACAGTATGTAGGAAATGACTTTACTTCGCCATACAATGATAACTGGGAT
GGCCGCAATAACGTAGAAAATGTATTTATTAATGCACCACAAAGCGGGACGTATACAATT
GAGGTACAGGCTTATAACGTACCGGTTGGACCACAGACCTTCTCGTTGGCAATTGTGAAT
TAA

# Drug_Target_1_General_Function:
Involved in peptidase activity

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4623

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
67992

# Drug_Target_1_Name:
Protease

# Drug_Target_1_Number_of_Residues:
640

# Drug_Target_1_PDB_ID:
1WME

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00082	Peptidase_S8
PF04151	PPC

# Drug_Target_1_Protein_Sequence:
>Protease
MRKKKKVFLSVLSAAAILSTVALSNPSAGGARNFDLDFKGIQTTTDAKGFSKQGQTGAAA
FLVESENVKLPKGLQKKLETVPANNKLHIIQFNGPILEETKQQLEKTGAKILDYIPDYAY
IVEYEGDVKSATSTIEHVESVEPYLPIYRIDPQLFTKGASELVKAVALDTKQKNKEVQLR
GIEQIAQFAISNDVLYITAKPEYKVMNDVARGIVKADVAQSSYGLYGQGQIVAVADTGLD
TGRNDSSMHEAFRGKITALYALGRTNNANDTNGHGTHVAGSVLGNGSTNKGMAPQANLVF
QSIMDSGGGLGGLPSNLQTLFSQAYSAGARIHTNSWGAAVNGAYTTDSRNVDDYVRKNDM
TILFAAGNEGPNGGTISAPGTAKNAITVGATENLRPSFGSYADNINHVAQFSSRGPTKDG
RIKPDVMAPGTFILSARSSLAPDSSFWANHDSKYAYMGGTSMATPIVAGNVAQLREHFVK
NRGITPKPSLLKAALIAGAADIGLGYPNGNQGWGRVTLDKSLNVAYVNESSSLSTSQKAT
YSFTATAGKPLKISLVWSDAPASTTASVTLVNDLDLVITAPNGTQYVGNDFTSPYNDNWD
GRNNVENVFINAPQSGTYTIEVQAYNVPVGPQTFSLAIVN

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q93UV9

# Drug_Target_1_SwissProt_Name:
Q93UV9_9BACI

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
8.78

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Membrane

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
APP

# Drug_Target_2_GenBank_ID_Gene:
X06989

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
APP

# Drug_Target_2_Gene_Sequence:
>2256 bp
ATGCTGCCCGGTTTGGCACTGCTCCTGCTGGCCGCCTGGACGGCTCGGGCGCTGGAGGTA
CCCACTGATGGTAATGCTGGCCTGCTGGCTGAACCCCAGATTGCCATGTTCTGTGGCAGA
CTGAACATGCACATGAATGTCCAGAATGGGAAGTGGGATTCAGATCCATCAGGGACCAAA
ACCTGCATTGATACCAAGGAAGGCATCCTGCAGTATTGCCAAGAAGTCTACCCTGAACTG
CAGATCACCAATGTGGTAGAAGCCAACCAACCAGTGACCATCCAGAACTGGTGCAAGCGG
GGCCGCAAGCAGTGCAAGACCCATCCCCACTTTGTGATTCCCTACCGCTGCTTAGTTGGT
GAGTTTGTAAGTGATGCCCTTCTCGTTCCTGACAAGTGCAAATTCTTACACCAGGAGAGG
ATGGATGTTTGCGAAACTCATCTTCACTGGCACACCGTCGCCAAAGAGACATGCAGTGAG
AAGAGTACCAACTTGCATGACTACGGCATGTTGCTGCCCTGCGGAATTGACAAGTTCCGA
GGGGTAGAGTTTGTGTGTTGCCCACTGGCTGAAGAAAGTGACAATGTGGATTCTGCTGAT
GCGGAGGAGGATGACTCGGATGTCTGGTGGGGCGGAGCAGACACAGACTATGCAGATGGG
AGTGAAGACAAAGTAGTAGAAGTAGCAGAGGAGGAAGAAGTGGCTGAGGTGGAAGAAGAA
GAAGCCGATGATGACGAGGACGATGAGGATGGTGATGAGGTAGAGGAAGAGGCTGAGGAA
CCCTACGAAGAAGCCACAGAGAGAACCACCAGCATTGCCACCACCACCACCACCACCACA
GAGTCTGTGGAAGAGGTGGTTCGAGAGGTGTGCTCTGAACAAGCCGAGACGGGGCCGTGC
CGAGCAATGATCTCCCGCTGGTACTTTGATGTGACTGAAGGGAAGTGTGCCCCATTCTTT
TACGGCGGATGTGGCGGCAACCGGAACAACTTTGACACAGAAGAGTACTGCATGGCCGTG
TGTGGCAGCGCCATTCCTACAACAGCAGCCAGTACCCCTGATGCCGTTGACAAGTATCTC
GAGACACCTGGGGATGAGAATGAACATGCCCATTTCCAGAAAGCCAAAGAGAGGCTTGAG
GCCAAGCACCGAGAGAGAATGTCCCAGGTCATGAGAGAATGGGAAGAGGCAGAACGTCAA
GCAAAGAACTTGCCTAAAGCTGATAAGAAGGCAGTTATCCAGCATTTCCAGGAGAAAGTG
GAATCTTTGGAACAGGAAGCAGCCAACGAGAGACAGCAGCTGGTGGAGACACACATGGCC
AGAGTGGAAGCCATGCTCAATGACCGCCGCCGCCTGGCCCTGGAGAACTACATCACCGCT
CTGCAGGCTGTTCCTCCTCGGCCTCGTCACGTGTTCAATATGCTAAAGAAGTATGTCCGC
GCAGAACAGAAGGACAGACAGCACACCCTAAAGCATTTCGAGCATGTGCGCATGGTGGAT
CCCAAGAAAGCCGCTCAGATCCGGTCCCAGGTTATGACACACCTCCGTGTGATTTATGAG
CGCATGAATCAGTCTCTCTCCCTGCTCTACAACGTGCCTGCAGTGGCCGAGGAGATTCAG
GATGAAGTTGATGAGCTGCTTCAGAAAGAGCAAAACTATTCAGATGACGTCTTGGCCAAC
ATGATTAGTGAACCAAGGATCAGTTACGGAAACGATGCTCTCATGCCATCTTTGACCGAA
ACGAAAACCACCGTGGAGCTCCTTCCCGTGAATGGAGAGTTCAGCCTGGACGATCTCCAG
CCGTGGCATTCTTTTGGGGCTGACTCTGTGCCAGCCAACACAGAAAACGAAGTTGAGCCT
GTTGATGCCCGCCCTGCTGCCGACCGAGGACTGACCACTCGACCAGGTTCTGGGTTGACA
AATATCAAGACGGAGGAGATCTCTGAAGTGAAGATGGATGCAGAATTCCGACATGACTCA
GGATATGAAGTTCATCATCAAAAATTGGTGTTCTTTGCAGAAGATGTGGGTTCAAACAAA
GGTGCAATCATTGGACTCATGGTGGGCGGTGTTGTCATAGCGACAGTGATCGTCATCACC
TTGGTGATGCTGAAGAAGAAACAGTACACATCCATTCATCATGGTGTGGTGGAGGTTGAC
GCCGCTGTCACCCCAGAGGAGCGCCACCTGTCCAAGATGCAGCAGAACGGCTACGAAAAT
CCAACCTACAAGTTCTTTGAGCAGATGCAGAACTAG

# Drug_Target_2_General_Function:
Involved in binding

# Drug_Target_2_General_References:
12859342	Tang K, Wang C, Shen C, Sheng S, Ravid R, Jing N: Identification of a novel alternative splicing isoform of human amyloid precursor protein gene, APP639. Eur J Neurosci. 2003 Jul;18(1):102-8.
1587857	Konig G, Monning U, Czech C, Prior R, Banati R, Schreiter-Gasser U, Bauer J, Masters CL, Beyreuther K: Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem. 1992 May 25;267(15):10804-9.
2110105	Yoshikai S, Sasaki H, Doh-ura K, Furuya H, Sakaki Y: Genomic organization of the human amyloid beta-protein precursor gene. Gene. 1990 Mar 15;87(2):257-63.
2783775	Lemaire HG, Salbaum JM, Multhaup G, Kang J, Bayney RM, Unterbeck A, Beyreuther K, Muller-Hill B: The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons. Nucleic Acids Res. 1989 Jan 25;17(2):517-22.
2881207	Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19-25;325(6106):733-6.
2893289	Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F: A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988 Feb 11;331(6156):525-7.
9108164	Hattori M, Tsukahara F, Furuhata Y, Tanahashi H, Hirose M, Saito M, Tsukuni S, Sakaki Y: A novel method for making nested deletions and its application for sequencing of a 300 kb region of human APP locus. Nucleic Acids Res. 1997 May 1;25(9):1802-8.

# Drug_Target_2_HGNC_ID:
HGNC:620

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5800

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
86944

# Drug_Target_2_Name:
Amyloid beta A4 protein

# Drug_Target_2_Number_of_Residues:
770

# Drug_Target_2_PDB_ID:
1RW6

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00014	Kunitz_BPTI
PF02177	A4_EXTRA
PF03494	Beta-APP

# Drug_Target_2_Protein_Sequence:
>Amyloid beta A4 protein
MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTK
TCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVG
EFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFR
GVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEE
EADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPC
RAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARD
PVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQA
KNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITAL
QAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYER
MNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTET
KTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTN
IKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITL
VMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-17

# Drug_Target_2_Specific_Function:
The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis

# Drug_Target_2_SwissProt_ID:
P05067

# Drug_Target_2_SwissProt_Name:
A4_HUMAN

# Drug_Target_2_Synonyms:
ABPP
APP
APPI
Alzheimer disease amyloid protein
Amyloid beta A4 protein precursor
CVAP
Cerebral vascular amyloid peptide
PN-II
PreA4
Protease nexin-II

# Drug_Target_2_Theoretical_pI:
4.45

# Drug_Target_2_Transmembrane_Regions:
700-723

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AJ438208

# Drug_Target_3_GenBank_ID_Protein:
19571548

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
katA

# Drug_Target_3_Gene_Sequence:
>1512 bp
ATGGAGCACCAGAAGACGACGCCGCACGCGACCGGCTCGACCCGCCAGAACGGCGCCCCG
GCCGTCAGCGACCGCCAGTCCCTGACCGTGGGCAGCGAGGGTCCCATCGTCCTGCACGAC
ACCCACCTGCTGGAGACCCACCAGCACTTCAACCGCATGAACATCCCGGAGCGCCGCCCG
CACGCCAAGGGCTCGGGCGCGTTCGGCGAGTTCGAGGTGACCGAGGACGTGTCGAAGTAC
ACCAAGGCCCTCGTGTTCCAGCCGGGCACGAAGACCGAGACCCTCCTGCGCTTCTCCACC
GTGGCCGGCGAGCTCGGCTCCCCGGACACCTGGCGCGACGTGCGCGGCTTCGCGCTGCGC
TTCTACACCGAGGAGGGCAACTACGACCTCGTCGGCAACAACACCCCGATCTTCTTCCTG
CGCGACCCCATGAAGTTCACCCACTTCATCCGCTCGCAGAAGCGCCTGCCGGACTCCGGC
CTGCGCGATGCCACCATGCAGTGGGACTTCTGGACCAACAACCCCGAGTCGGCGCACCAG
GTGACCTACCTGATGGGCCCGCGCGGCCTGCCCCGCACCTGGCGTGAGATGAACGGCTAC
GGCTCCCACACCTACCTGTGGGTCAACGCCCAGGGTGAGAAGCACTGGGTGAAGTACCAC
TTCATCTCCCAGCAGGGCGTGCACAACCTCTCGAACGACGAGGCCACCAAGATCGCCGGC
GAGAACGCCGACTTCCACCGCCAGGACCTGTTCGAGTCCATCGCCAAGGGCGACCACCCC
AAGTGGGACCTCTACATCCAGGCGATCCCCTACGAGGAGGGCAAGACCTACCGGTTCAAC
CCCTTCGACCTGACGAAGACGATCTCCCAGAAGGACTACCCGCGCATCAAGGTCGGCACG
CTGACCCTGAACCGCAACCCGGAGAACCACTTCGCGCAGATCGAGTCCGCCGCGTTCAGC
CCGAGCAACACCGTGCCGGGCATCGGCCTGTCCCCGGACCGCATGCTCCTGGGCCGCGCC
TTCGCGTACCACGACGCGCAGCTGTACCGCGTGGGCGCCCACGTGAACCAGCTGCCGGTG
AACCGTCCCAAGAACGCGGTGCACAACTACGCCTTCGAGGGCCAGATGTGGTACGACCAC
ACCGGCGACCGCTCCACCTACGTGCCGAACTCCAACGGCGACTCCTGGTCGGACGAGACC
GGCCCGGTGGACGACGGCTGGGAGGCCGACGGCACCCTGACCCGTGAGGCCCAGGCGCTG
CGCGCGGACGACGACGACTTCGGCCAGGCCGGCACCCTCGTCCGCGAGGTCTTCTCGGAC
CAGGAGCGTGACGACTTCGTGGAGACCGTGGCCGGCGCGCTGAAGGGTGTCCGCCAGGAC
GTCCAGGCCCGCGCCTTCGAGTACTGGAAGAACGTGGACGCCACGATCGGCCAGCGCATC
GAGGACGAGGTCAAGCGCCACGAGGGCGACGGCATCCCGGGCGTCGAGGCCGGCGGCGAG
GCCCGCATGTGA

# Drug_Target_3_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_3_General_References:
12454454	Murshudov GN, Grebenko AI, Brannigan JA, Antson AA, Barynin VV, Dodson GG, Dauter Z, Wilson KS, Melik-Adamyan WR: The structures of Micrococcus lysodeikticus catalase, its ferryl intermediate (compound II) and NADPH complex. Acta Crystallogr D Biol Crystallogr. 2002 Dec;58(Pt 12):1972-82. Epub 2002 Nov 23.
1426241	Murshudov GN, Melik-Adamyan WR, Grebenko AI, Barynin VV, Vagin AA, Vainshtein BK, Dauter Z, Wilson KS: Three-dimensional structure of catalase from Micrococcus lysodeikticus at 1.5 A resolution. FEBS Lett. 1992 Nov 9;312(2-3):127-31.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3249

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
56906

# Drug_Target_3_Name:
Catalase

# Drug_Target_3_Number_of_Residues:
503

# Drug_Target_3_PDB_ID:
1GWH

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_3_Protein_Sequence:
>Catalase
MEHQKTTPHATGSTRQNGAPAVSDRQSLTVGSEGPIVLHDTHLLETHQHFNRMNIPERRP
HAKGSGAFGEFEVTEDVSKYTKALVFQPGTKTETLLRFSTVAGELGSPDTWRDVRGFALR
FYTEEGNYDLVGNNTPIFFLRDPMKFTHFIRSQKRLPDSGLRDATMQWDFWTNNPESAHQ
VTYLMGPRGLPRTWREMNGYGSHTYLWVNAQGEKHWVKYHFISQQGVHNLSNDEATKIAG
ENADFHRQDLFESIAKGDHPKWDLYIQAIPYEEGKTYRFNPFDLTKTISQKDYPRIKVGT
LTLNRNPENHFAQIESAAFSPSNTVPGIGLSPDRMLLGRAFAYHDAQLYRVGAHVNQLPV
NRPKNAVHNYAFEGQMWYDHTGDRSTYVPNSNGDSWSDETGPVDDGWEADGTLTREAQAL
RADDDDFGQAGTLVREVFSDQERDDFVETVAGALKGVRQDVQARAFEYWKNVDATIGQRI
EDEVKRHEGDGIPGVEAGGEARM

# Drug_Target_3_Reaction:
2 H2O2 = O2 + 2 H2O

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_3_SwissProt_ID:
P29422

# Drug_Target_3_SwissProt_Name:
CATA_MICLU

# Drug_Target_3_Synonyms:
EC 1.11.1.6

# Drug_Target_3_Theoretical_pI:
5.97

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB02235
